Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4468 Target Snapshot

Histamine H4 receptor · SINGLE PROTEIN · Rattus norvegicus

178Compounds
59Assays
3Approved Drugs
178.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q91ZY1. Use UniProt Q91ZY1 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q91ZY1 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histamine H4 receptor as ChEMBL target CHEMBL4468, mapped to UniProt Q91ZY1. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histamine H4 receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL4468
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q91ZY1
Histamine H4 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histamine H4 receptor is the right protein anchor across sources, using UniProt Q91ZY1 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistamine H4 receptor
UniProt AccessionQ91ZY1
Component TypeProtein
Sequence Length391 aa

Histamine H4 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histamine H4 receptor, mapped to UniProt Q91ZY1. Sequence length is 391 aa.

Mapped IDQ91ZY1
Review nameHistamine H4 receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

3
Approved
3
Phase II
Assay Mix

Activity Type Distribution

KI50.0
EC50122.0
KD6.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4454158 10.3 EC50 0.05012 Preclinical
CHEMBL4443126 9.21 EC50 0.6166 Preclinical
CHEMBL4439142 9.19 EC50 0.6457 Preclinical
CHEMBL4543119 8.93 EC50 1.175 Preclinical
CHEMBL4445423 8.86 EC50 1.38 Preclinical
CHEMBL1079516 8.84 Ki 1.445 Preclinical
CHEMBL523225 8.84 Ki 1.445 Preclinical
CHEMBL592379 8.81 Ki 1.549 Preclinical
CHEMBL4455324 8.75 EC50 1.778 Preclinical
CHEMBL129198 8.62 Ki 2.4 Preclinical
Distribution

pChEMBL Value Distribution

17
5.0
13
5.5
15
6.0
37
6.5
27
7.0
23
7.5
21
8.0
12
8.5
2
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

HISTAMINE
CHEMBL90
Approved 1939
Assay Landscape

Assay Landscape

59
Total Assays
108
Tested Compounds
2
Assay Types
Binding — 32 assays, 51 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 20 31 7.5
single protein format 11 20 7.7
cell membrane format 1 0
Functional — 27 assays, 108 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 20 99 6.6
assay format 5 5 6.7
single protein format 2 4 5.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine